๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical and radiographic presentation of superior mesenteric vein thrombosis in Crohn's disease: A single center experience

โœ Scribed by Uri Kopylov; Marianne M. Amitai; Aharon Lubetsky; Rami Eliakim; Yehuda Chowers; Shomron Ben-Horin

Book ID
119223430
Publisher
Oxford University Press
Year
2012
Tongue
English
Weight
628 KB
Volume
6
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Durability of infliximab in Crohn's dise
Durability of infliximab in Crohn's disease: A single-center experience
โœ Jason E. Gonzaga; Ashwin N. Ananthakrishnan; Mazen Issa; Dawn B. Beaulieu; Sue S ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB ๐Ÿ‘ 2 views

Background: Infliximab is effective maintenance for moderate to severe Crohn's disease (CD); however, problems with immunogenicity and decreased efficacy often complicate long-term use. Durability of infliximab maintenance therapy over multiple years has not been defined. ## Methods: This was a r

Safety of infliximab in Crohn's disease:
Safety of infliximab in Crohn's disease: A large single-center experience
โœ H. Hamzaoglu; J. Cooper; M. Alsahli; K.R. Falchuk; M.A. Peppercorn; R.J. Farrell ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 135 KB ๐Ÿ‘ 2 views

## Background: The aim of this study was to evaluate the shortand long-term safety experience of infliximab treatment in patients with Crohn's disease (CD) in clinical practice. ## Methods: The medical records of 297 consecutive patients with CD treated with infliximab at the Beth Israel Deacon

Efficacy and safety of tacrolimus in ref
Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: A single-center experience
โœ Aaron Benson; Terrence Barrett; Marshall Sparberg; Alan L. Buchman ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 129 KB ๐Ÿ‘ 2 views

## Background: The published experience regarding the use of tacrolimus in crohn's disease (cd) and ulcerative colitis (uc) refractory to more commonly used medical therapy has been fairly limited. our objective was to describe our experience with its use in a cohort of patients which, to our knowl